An outbreak of community-acquired pseudomonas aeruginosa pneumonia in a setting of high water stress

Thadathilankal-Jess John, Usha Lalla, J. J. F. Taljaard, K John, J Slabbert, Coenraad F.N. Koegelenberg

QJM · 2017 · 14 citations · 6 references

Concepts

Abstract

Community acquired pneumonia (CAP) remains a cause of considerable morbidity and mortality throughout the world. Mortality is improved by early initiation of antibiotics to which the causative organism(s) are susceptible, which most often is empiric and guided by local susceptibility patterns.1 Pseudomonas aeruginosa, is an important cause of nosocomial infections and community acquired infections in immunocompromised patients and patients with structural lung disease. It has intrinsically advanced antibiotic resistance mechanisms notably against recommended empiric antibiotic therapy for community acquired pneumonia.1,2 Over a 10-year period until the start of 2017, there have been no admissions to our medical intensive care unit with community-acquired P. aeruginosa pneumonia (defined as cultures confirming infection taken within 48 h of first admission to hospital and no recent exposure to a chronic care facility or other health care environments). During a 3-month period (March–May 2017), we admitted at least nine documented cases of culture-confirmed (tracheal aspirates and/or blood culture) community-acquired P. aeruginosa pneumonia (detailed in Table 1). All cases were susceptible to first line anti-pseudomonal agents (anti-pseudomonal cephalosporins, piperacillin-tazobactam, ciprofloxacin and aminoglycosides), unlike the extended resistance patterns often seen in nosocomial P. aeruginosa infections.2 Moreover co-infections were not observed in any of the cases.

References

6